Literature DB >> 629744

The binding of 2,4,6-trinitrophenyl derivatives to the mouse myeloma immunoglobulin A protein MOPC 315.

S K Dower, P Gettins, R Jackson, R A Dwek, D Givol.   

Abstract

The binding of Tnp (2,4,6-trinitrophenyl) derivatives to the Fv fragment (variable region of heavy and light chains) of the mouse myeloma IgA protein MOPC 315 was investigated by 270MHz proton nuclear magnetic resonance. Two of the haptens, Tnp-glycine and Tnp-l-aspartate, are in fast exchange with the Fv fragment, and the changes in chemical shifts for both protein and hapten resonances were determined by titrations. For the tightly binding hapten epsilon-N-Tnp-alpha-N-acetyl-l-lysine, which is in slow exchange with the Fv fragment, the changes in chemical shifts for the hapten H(3)+H(5) resonances were determined by cross-saturation. By using these data and the known structure of the combining site of protein MOPC 315 [Dwek, Wain-Hobson, Dower, Gettins, Sutton, Perkins & Givol (1977), Nature (London) 266, 31-37] the mode of binding of Tnp derivatives is deduced by ring-current calculations. The trinitrophenyl ring stacks with tryptophan-93(L) (light chain) in the ;aromatic box' formed by tryptophan-93(L), tyrosine-34(L) and phenyl-alanine-34(H) (heavy chain). Further evidence for the stacking interaction with a tryptophan residue is provided by the similarity of the optical-difference spectra observed with Tnp-aminomethylphosphonate in the presence of either the Fab fragment (light chain and N-terminal half of heavy chain) of protein MOPC 315 or tryptophan. These data show that the modes of binding of all the Tnp derivatives are very similar, despite a 100-fold range in their affinities. It is also concluded that the modes of binding of Dnp (2,4-dinitrophenyl) and Tnp derivatives to protein MOPC 315 are very similar, and that the structural basis for this is that the aromatic box is large enought to allow the trinitrophenyl ring to stack with tryptophan-93(L) while still forming hydrogen bonds to asparagine-36(L) and tyrosine-34(L).

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629744      PMCID: PMC1184207          DOI: 10.1042/bj1690179

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Structure of an antibody combining site by magnetic resonance.

Authors:  R A Dwek; S Wain-Hobson; S Dower; P Gettins; B Sutton; S J Perkins; D Givol
Journal:  Nature       Date:  1977-03-03       Impact factor: 49.962

2.  Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.

Authors:  R A Dwek; D Givol; R Jones; A C McLaughlin; S Wain-Hobson; A I White; C Wright
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Model-building studies of antigen-binding sites: the hapten-binding site of mopc-315.

Authors:  E A Padlan; D R Davies; I Pecht; D Givol; C Wright
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

4.  Localization of antibody-combining sites within the variable portions of heavy and light chains.

Authors:  D Inbar; J Hochman; D Givol
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

5.  Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315.

Authors:  H N Eisen; E S Simms; M Potter
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

6.  Kinetic mapping of the antibody combining site by chemical relaxation spectrometry.

Authors:  D Haselkorn; S Friedman; D Givol; I Pecht
Journal:  Biochemistry       Date:  1974-05-07       Impact factor: 3.162

7.  Thermodynamics of hapten binding to MOPC 315 and MOPC 460 mouse myeloma proteins.

Authors:  M F Johnston; B G Barisas; J M Sturtevant
Journal:  Biochemistry       Date:  1974-01-15       Impact factor: 3.162

8.  Specificity of interactions of hapten side chains with the combining site of the myeloma protein MOPC 315.

Authors:  S Wain-Hobson; S K Dower; P Gettins; D Givol; A C McLaughlin; I Pecht; C A Sunderland; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

9.  The combining site of the dinitrophenyl-binding immunoglobulin A myeloma protein MOPC 315.

Authors:  S K Dower; S Wain-Hobson; P Gettins; D Givol; W R Jackson; S J Perkins; C A Sunderland; B J Sutton; C E Wright; R A Dwek
Journal:  Biochem J       Date:  1977-08-01       Impact factor: 3.857

10.  Specificity of the immune response to the 2,4-dinitrophenyl and 2,4,6-trinitrophenyl groups. Ligand binding and fluorescence properties of cross-reacting antibodies.

Authors:  J R Little; H N Eisen
Journal:  J Exp Med       Date:  1969-02-01       Impact factor: 14.307

View more
  3 in total

1.  The role of nitro groups in the binding of nitroaromatics to protein MOPC 315.

Authors:  P Gettins; D Givol; R A Dwek
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

2.  Rational Design of Peptide-Functionalized Surface Plasmon Resonance Sensor for Specific Detection of TNT Explosive.

Authors:  Jin Wang; Masaki Muto; Rui Yatabe; Takeshi Onodera; Masayoshi Tanaka; Mina Okochi; Kiyoshi Toko
Journal:  Sensors (Basel)       Date:  2017-09-30       Impact factor: 3.576

3.  B cell receptor ligation induces display of V-region peptides on MHC class II molecules to T cells.

Authors:  Peter Csaba Huszthy; Ramakrishna Prabhu Gopalakrishnan; Johanne Tracey Jacobsen; Ole Audun Werner Haabeth; Geir Åge Løset; Ranveig Braathen; Karl Schenck; Anders Aune Tveita; Ludvig Andre Munthe; Bjarne Bogen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-03       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.